tyvense 70 mg capsules, hard
takeda pharmaceuticals international ag ireland branch - lisdexamfetamine dimesylate - capsule, hard - psychoanaleptics
xyntha 500 iu
pfizer pharmaceuticals israel ltd - moroctocog alfa - lyophylized powder and solvent for solution for injection - moroctocog alfa 500 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency)
xyntha 1000 iu
pfizer pharmaceuticals israel ltd - moroctocog alfa - powder and solvent for solution for injection - moroctocog alfa 1000 iu/vial - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency)
diprofol 1 %
taro international ltd, israel - propofol - emulsion for injection or infusion - propofol 10 mg/ml - propofol - propofol - diprofol 1% is a short-acting intravenous general anaesthetic for:• induction and maintenance of general anaesthesia in adults and children > 1 month.• sedation of ventilated patients > 16 years of age in the intensive care unit.• sedation for diagnostic and surgical procedures, alone or in combination with local or regional anaesthesia in adults and children > 1 month..
diprofol 1 %
taro international ltd, israel - propofol - emulsion for injection or infusion - propofol 10 mg/ml - propofol - propofol - diprofol 1% is a short-acting intravenous general anaesthetic for:• induction and maintenance of general anaesthesia in adults and children > 1 month.• sedation of ventilated patients > 16 years of age in the intensive care unit.• sedation for diagnostic and surgical procedures, alone or in combination with local or regional anaesthesia in adults and children > 1 month.
diprofol 2 %
taro international ltd, israel - propofol - emulsion for injection or infusion - propofol 20 mg/ml - propofol - propofol - propofol 2% is a short- acting intravenous general anaesthetic for:• induction and maintenance of general anaethesia in adults and children > 3 years.• sedation of ventilated patients >16 years of age in the intensive care unit.• sedation for diagnostic and surgical procedures, alone or in combination with local or regional anaesthesia in adults and children > 3 years.
dopacis 90 mbq/ml solution for injection
cis bio international - fluorodopa (18 f) - solution for injection - 90 mbq/ml - other diagnostic radiopharmaceuticals for tumour detection
tekcis 2-50 gbq radionuclide generator
cis bio international - sodium pertechnetate (99m tc) - radionuclide generator - 2-50 gigabecquerel(s) - various thyroid diagnostic radiopharmaceuticals; technetium (99mtc) pertechnetate
dopacis 90 mbq/ml solution for injection
cis bio international route nationale 306-saclay, bp 32, 91192, gif-sur-yvette cedex, france - fluorodopa - solution for injection - fluorodopa (18f) 90 mbq/ml - diagnostic radiopharmaceuticals
tyvense 20 milligram capsules hard
shire pharmaceutical contracts ltd - lisdexamfetamine dimesylate - capsules hard - 20 milligram - phenylethylamine derivatives - centrally acting sympathomimetics - it is indicated as part of a comprehensive treatment programme for attention deficit/hyperactivity disorder (adhd) in children aged 6 years and over when response to previous methylphenidate treatment is considered clinically inadequate